Under Armour, Bitcoin, AMD, Biogen, Gilead, Pfizer – Monster Commentary
The S&P 500 had a relatively uneventful day, with the index finishing the day down less than 20 bps. But the thing to take note of is how the index has now failed right at 2,805 three times. Big deal? Likely not, and I would suspect we blow through that resistance tomorrow. The downside now is around 2,790, and with the start of significant earnings next week, I get the sense investor want go long into some of these upcoming results.
Join our 448 Daily Subscribers And Get This Commentary In Your E-Mail!
The AMD seller appears to have gone up to the $12.50 level now; they must have caught word of our commentary yesterday, that is a joke. But anyway the chart continues to tell the story, and for now, AMD shares seem to want to go higher. Maybe the seller should try the $12.75 level tomorrow. (meant to be funny, laugh!)
Biogen shares continue to trend nicely higher, with the next big test for the stock looming around $355. That is where gap from years ago is entirely closed, and a rise above $355 likely sends Biogen’s stock on to all-time highs. Also, we can see the stock has some room to rise before the relative strength index (RSI) gets to overbought levels.
Gilead shares have had a massive breakout and could be on their way back to $92. If Gilead and Biogen get moving, the rest of the sector follows.
Have you seen Pfizer lately? The stock looks like it ready to breakout in a big way.
Under Armour looks terrible here, with a clear breakdown and a stock price that appears ready to fall to $11.55.
Even fundamentally Under Armour is grossly overvalued. Shares trade at nearly 42 times 2019 earnings estimates of $0.32. Compare that to Nike’s 24 times, and Lulu’s 25 times.
Even on an EV/EBITDA ratio, Under Armour is first now on par with Nike, and is still well north of Lulu. It comes down to simple common sense, does Under Amour deserve to trade at premium or on par with Nike? Not a chance.
This chart of Bitcoin tells it all. The crypto-currency broke support around 11,800 and then it failed to rise through when it acted as resistance. See ya at 7,700.
Sign-up for our premium content on Seeking Alpha Market Place – “Reading The Markets” and a get Two Week Free Trial Period
Premium Content: Benefits include the ability to reach out to Mike with questions through a chat room, direct message, or comments.
Free Articles Written By Mike:
We offer daily market commentaries sent directly to your inbox or follow us on Twitter.
Join our 448 Daily Subscribers And Get This Commentary In Your E-Mail! Subscribe
Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future.
© 2017 Mott Capital Management, LLC. Use, publication or reproduction in any media prohibited without the permission of the copyright holder.